WA biotech gets US approval for pearl bone graft
Marine Biomedical received FDA clearance to use WA mother-of-pearl for treating bone fractures in the United States.
The new product PearlBone is the first graft made from nacre harvested from oyster shells in the Kimberley region. This unique material was specifically developed to help repair damaged bones effectively for patients in need of treatment.
Chief executive Rolee Kumar explained that the substance contains building blocks identical to human bone tissue found naturally within the body. She stated that studies show this material facilitates healing without causing any harmful reactions during the repair process.
The United States represents the largest orthopaedic market globally with a sector value reaching one point one billion US dollars. This regulatory win allows the company to access a massive market before potentially returning the product to Australian customers.
Marine Biomedical joined forces with a local Broome pearling business and university experts to create this solution. Shells collected from the farm are cleaned and prepared before moving to the processing site in Broome for final preparation.
“The next point is obviously making sales, getting patients and benefiting from that and getting surgeons using it”

